Systemic Treatment in Advanced Thymic Epithelial Tumors. Insights From a Prospective Cohort of 888 Patients Enrolled in RYTHMIC

被引：0
|
作者：
Girard, Nicolas [1 ]
Dansin, Eric [2 ]
Lena, Herve [3 ]
Pichon, Eric [4 ]
Thomas, Pascal-Alexandre [5 ]
Mazieres, Julien [6 ]
Thiberville, Luc [7 ]
Westeel, Virginie [8 ]
Zalcman, Gerard [9 ]
Clement-Duchene, Christelle [10 ]
Massard, Gilbert [11 ]
Quantin, Xavier [12 ]
Bennouna, Jaafar [13 ]
Fournel, Pierre [14 ]
Molina, Thierry [15 ]
Besse, Benjamin [16 ]
机构：
[1] Hosp Civils Lyon, Hop Louis Pradel, Lyon, France
[2] Ctr Oscar Lambret, F-59020 Lille, France
[3] Ctr Hosp Univ, Rennes, France
[4] CHU Tours, Hop Bretonneau, Tours, France
[5] Assistance Publ Hop Marseille, Marseille, France
[6] Ctr Hosp Univ, Hop Larrey, Toulouse, France
[7] Ctr Hosp Univ, Rouen, France
[8] CHU Besancon, F-25030 Besancon, France
[9] CHU Caen, F-14000 Caen, France
[10] Ctr Hosp Univ, Vandoeuvre Les Nancy, France
[11] Hop Univ, Strasbourg, France
[12] CHU Montpellier, Montpellier, France
[13] Inst Cancerol Ouest, St Herblain, France
[14] Inst Cancerol Lucien Neuwirth, St Priest En Jarez, France
[15] Assistance Publ Hop Paris, Paris, France
[16] Gustave Roussy Canc Campus, Villejuif, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Thymoma; Thymic carcinoma; chemotherapy; Reccurence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI25.08
引用
收藏
页码：S353 / S354
页数：2
相关论文
共 37 条
  • [31] Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer final - results from the prospective German TLK cohort study
    von Verschuer, Ulla
    Schnell, Roland
    Tessen, Hans Werner
    Eggert, Jochen
    Binninger, Adrian
    Spring, Lisa
    Jaenicke, Martina
    Marschner, Norbert
    LUNG CANCER, 2017, 112 : 216 - 224
  • [32] Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma
    Hegewisch-Becker, Susanna
    Aldaoud, Ali
    Wolf, Thomas
    Krammer-Steiner, Beate
    Linde, Hartmut
    Scheiner-Sparna, Renate
    Hamm, David
    Jaenicke, Martina
    Marschner, Norbert
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (05) : 981 - 990
  • [33] OVERALL SURVIVAL AND PATIENT-REPORTED IMPAIRMENT BY FATIGUE, PAIN AND TREATMENT TIME IN PATIENTS WITH ADVANCED BREAST CANCER IN ROUTINE PRACTICE: RESULTS FROM THE PROSPECTIVE GERMAN TMK COHORT STUDY
    Marschner, Norbert
    Fietz, Thomas
    Rauh, Jacqueline
    Nusch, Arnd
    Soeling, Ulrike
    Frank, Melanie
    Kruggel, Lisa
    Jaenicke, Martina
    BREAST, 2017, 36 : S45 - S45
  • [34] Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
    Liang, Sheng-Kai
    Keng, Li-Ta
    Chang, Chia-Hao
    Wen, Yueh-Feng
    Lee, Meng-Rui
    Yang, Ching-Yao
    Wang, Jann-Yuan
    Ko, Jen-Chung
    Shih, Jin-Yuan
    Yu, Chong-Jen
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [35] A Mediation Analysis of the Association Between Systemic Inflammation Response Index, in-Hospital Complications, and Poor Long-Term Functional Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: Insights from a Large Prospective Cohort Study
    Li, Tu
    Li, Runting
    Lin, Fa
    Chen, Xiaolin
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3697 - 3708
  • [36] Pharmacokinetic results from two phase I dose escalation studies of once daily oral treatment with BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.
    Stopfer, P
    Schaefer, HG
    Amelsberg, A
    Huisman, H
    Eskens, F
    Gietema, JA
    Briscoe, J
    Lewis, N
    Cohen, RB
    Marshall, J
    Verweij, J
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9075S - 9075S
  • [37] Baseline results from ACT-FASTER, a prospective cohort study exploring treatment patterns with fulvestrant and exemestane in postmenopausal patients with advanced hormone-receptor positive breast cancer under real-life conditions in Germany
    Ostermann, H.
    Maass, N.
    Possinger, K.
    Tesch, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 264 - 264
1234